in an attempt to identify pharmacokinetic factors that determine the response of acute myeloid leukemia ( aml ) patients to induction chemotherapy , we determined the concentrations of daunorubicin ( dnr ) and the main metabolite daunorubicinol ( dol ) in vivo and particularly evaluated the concentrations in blood and bone marrow nucleated cells .
C0023467
acute myeloid leukemia
C0011015
daunorubicin